» Articles » PMID: 27873219

Immortalization of Primary Microglia: a New Platform to Study HIV Regulation in the Central Nervous System

Overview
Journal J Neurovirol
Publisher Springer
Specialties Microbiology
Neurology
Date 2016 Nov 23
PMID 27873219
Citations 114
Authors
Affiliations
Soon will be listed here.
Abstract

The major reservoirs for HIV in the CNS are in the microglia, perivascular macrophages, and to a lesser extent, astrocytes. To study the molecular events controlling HIV expression in the microglia, we developed a reliable and robust method to immortalize microglial cells from primary glia from fresh CNS tissues and commercially available frozen glial cells. Primary human cells, including cells obtained from adult brain tissue, were transformed with lentiviral vectors expressing SV40 T antigen or a combination of SVR40 T antigen and hTERT. The immortalized cells have microglia-like morphology and express key microglial surface markers including CD11b, TGFβR, and P2RY12. Importantly, these cells were confirmed to be of human origin by sequencing. The RNA expression profiles identified by RNA-seq are also characteristic of microglial cells. Furthermore, the cells demonstrate the expected migratory and phagocytic activity, and the capacity to mount an inflammatory response characteristic of primary microglia. The immortalization method has also been successfully applied to a wide range of microglia from other species (macaque, rat, and mouse). To investigate different aspects of HIV molecular regulation in CNS, the cells have been superinfected with HIV reporter viruses and latently infected clones have been selected that reactive HIV in response to inflammatory signals. The cell lines we have developed and rigorously characterized will provide an invaluable resource for the study of HIV infection in microglial cells as well as studies of microglial cell function.

Citing Articles

Assessing models for microglial development and fetal programming: a critical review.

Schepanski S, Ngoumou G, Buss C, Seifert G Front Immunol. 2025; 16:1538920.

PMID: 39944696 PMC: 11814449. DOI: 10.3389/fimmu.2025.1538920.


Comprehensive SUMO Proteomic Analyses Identify HIV Latency-Associated Proteins in Microglia.

Imbert F, Langford D Cells. 2025; 14(3).

PMID: 39937027 PMC: 11817477. DOI: 10.3390/cells14030235.


Magnetoelectric Extracellular Vesicle Latency-Targeting (MELT) Nanotherapeutic for the Block-Lock-and-Kill HIV Eradication Strategy.

Andre M, Kolishetti N, Yndart A, Vashist A, Nair M, Raymond A Biomedicines. 2025; 13(1).

PMID: 39857731 PMC: 11762476. DOI: 10.3390/biomedicines13010147.


Agathisflavone Inhibits Viability and Modulates the Expression of miR-125b, miR-155, IL-6, and Arginase in Glioblastoma Cells and Microglia/Macrophage Activation.

da Silva K, Lima I, Dos Santos C, Nonaka C, Souza B, David J Molecules. 2025; 30(1.

PMID: 39795214 PMC: 11721753. DOI: 10.3390/molecules30010158.


18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile.

Germelli L, Angeloni E, Da Pozzo E, Tremolanti C, De Felice M, Giacomelli C Cell Mol Life Sci. 2025; 82(1):34.

PMID: 39757281 PMC: 11700965. DOI: 10.1007/s00018-024-05544-1.


References
1.
THOMAS W . Brain macrophages: evaluation of microglia and their functions. Brain Res Brain Res Rev. 1992; 17(1):61-74. DOI: 10.1016/0165-0173(92)90007-9. View

2.
Kettenmann H, Hanisch U, Noda M, Verkhratsky A . Physiology of microglia. Physiol Rev. 2011; 91(2):461-553. DOI: 10.1152/physrev.00011.2010. View

3.
Slepko N, Levi G . Progressive activation of adult microglial cells in vitro. Glia. 1996; 16(3):241-46. DOI: 10.1002/(SICI)1098-1136(199603)16:3<241::AID-GLIA6>3.0.CO;2-4. View

4.
Bray N, Pimentel H, Melsted P, Pachter L . Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016; 34(5):525-7. DOI: 10.1038/nbt.3519. View

5.
Kigerl K, de Rivero Vaccari J, Dietrich W, Popovich P, Keane R . Pattern recognition receptors and central nervous system repair. Exp Neurol. 2014; 258:5-16. PMC: 4974939. DOI: 10.1016/j.expneurol.2014.01.001. View